6-117675655-T-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138459.5(NUS1):c.-16T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_138459.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 55, with seizuresInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital disorder of glycosylation, type IAAInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_138459.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD2 exomes AF: 0.00 AC: 0AN: 118648 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000108 AC: 13AN: 1207502Hom.: 0 Cov.: 17 AF XY: 0.00000828 AC XY: 5AN XY: 604080 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 22
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at